Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliquis in kidney and lung transplant recipients
NCT04023760Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Jun 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), Atrial fibrillation (AFib), sponsored by University of Saskatchewan. Started Jun 2019; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04023760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023760.